LY3016859
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for LY3016859, covering 2017-08-15 to 2022-08-03. Get the full timeline:
Most recent: Clinical Trial Update: Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain [Phase 2]